Advertisement

Mumps: An Emergency Medicine-Focused Update

      Abstract

      Background

      Mumps is a Paramyxoviridae virus. This disease was rampant prior to introduction of the measles, mumps, and rubella vaccine, resulting in decreased incidence. This disease has demonstrated several outbreaks.

      Objective

      This review provides a focused evaluation of mumps, an update on outbreaks, management recommendations, and ways to decrease transmission.

      Discussion

      Clusters of mumps outbreaks continue to occur. The virus is a paramyxovirus, a single-stranded RNA virus. The vaccine can provide lifelong immunity if administered properly, though prior to 1967 and introduction of the vaccine, the virus was common. In the past decade, there have been several notable outbreaks. Humans are the only known hosts, with disease spread through exposure to droplets and saliva. Factors affecting transmission include age, compromised immunity, time of year, travel, and vaccination status. Upper respiratory symptoms, fever, and headache are common, with unilateral or bilateral parotitis, and the virus may spread to other systems. Diagnosis is clinical, though polymerase chain reaction and immunoglobulin testing are available. This review provides several recommendations for vaccine in pregnancy, patients living in close quarters, health care personnel, and those immunocompromised. Treatment is generally supportive, with emphasis on proper isolation to prevent widespread outbreaks. Although reporting regulations and procedures vary by state, mumps is reportable in most states.

      Conclusions

      Mumps is an easily spread virus. Although vaccination is the most effective way to prevent transmission, early recognition of the disease is crucial. As an emergency physician, it is important to recognize the clinical presentation, recommended testing, treatment, and isolation procedures.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Enders G.
        Paramyxoviruses.
        in: Baron S. Medical microbiology. 4th edn. University of Texas Medical Branch at Galveston, Galveston, TX1996 (Available at:)
        • Fiebelkorn A.P.
        • Barskey A.E.
        • Hickman C.J.
        • Bellini W.J.
        Chapter 9: Mumps. Manual for the surveillance of vaccine-preventable diseases.
        US Department of Health and Human Services, CDC, Atlanta, GA2012 (Available at:)
      1. Mumps: For Healthcare Providers. Centers For Disease Control and Prevention.
        (Available at)
        https://www.cdc.gov/mumps/hcp.html
        Date accessed: April 17, 2017
        (Page last reviewed: July 27, 2016. Page last updated: October 24, 2016)
        • Centers for Disease Control and Prevention (CDC)
        Update: multistate outbreak of mumps—United States, January 1–May 2, 2006.
        MMWR Morb Mortal Wkly Rep. 2006; 55: 559-563
        • Centers for Disease Control and Prevention (CDC)
        Update: mumps outbreak—New York and New Jersey, June 2009–January 2010.
        MMWR Morb Mortal Wkly Rep. 2010; 59: 125-129
        • Centers for Disease Control and Prevention (CDC)
        Mumps cases and outbreaks. Available at:.
        https://www.cdc.gov/mumps/outbreaks.html
        Date accessed: May 13, 2017
        (Page last reviewed: July 27, 2016. Page last updated: May 2, 2017)
        • Centers for Disease Control and Prevention (CDC)
        Mumps epidemic—Iowa, 2006.
        MMWR Morb Mortal Wkly Rep. 2006; 55: 366-368
        • The Arkansas Department of Health
        Mumps. Available at.
        • Washington State Department of Health
        Mumps outbreak.
        (Available at:)
      2. Infectious Disease Control Unit. Notifiable conditions 2017: Mumps Health Advisory IDPS.
        (Available at:)
        http://dshs.texas.gov/idcu/default.shtm
        Date accessed: April 17, 2017
        • Segarra L.M.
        The number of mumps cases in Texas just hit a 20-year high.
        Time Magazine – Public Health. April 12, 2017; (Available at:)
        • Oklahoma State Department of Health – Acute Disease Service
        Mumps outbreak summary.
        (Available at:)
        • Rubin S.A.
        • Carbone K.M.
        Mumps.
        in: Kasper D. Fauci A. Hauser S. Longo D. Jameson J. Loscalzo J. Harrison's principles of internal medicine. 19th edn. McGraw-Hill, New York, NY2014 (Available at:)
        • Cohen C.
        • White J.M.
        • Savage E.J.
        • et al.
        Vaccine effectiveness estimates, 2004–2005 mumps outbreak.
        England. Emerg Infect Dis. 2007; 13: 12-17
        • Johnstone J.A.
        • Ross C.A.C.
        • Dunn M.
        Meningitis and encephalitis associated with mumps infection: a 10-year survey.
        Arch Dis Childhood. 1972; 47: 647-651
        • Donahue M.
        • Schneider A.
        • Ukegbu U.
        • et al.
        Notes from the field: complications of mumps during a university outbreak among students who had received 2 doses of measles-mumps-rubella vaccine – Iowa, July 2015 – May 2016.
        MMWR Morb Mortal Wkly Rep. 2017; 66: 390-391
        • McQuone S.J.
        Acute viral and bacterial infections of the salivary glands.
        Otolaryngol Clin North Am. 1999; 32: 793-811
        • Barrabeig I.
        • Costa J.
        • Rovira A.
        • et al.
        Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, Spain.
        Hum Vaccin Immunother. 2014; 11: 282-287
        • Centers for Disease Control and Prevention (CDC)
        Mumps: general laboratory testing.
        US Department of Health and Human Services, CDC, Atlanta, GA2017 (Available at:)
        • Afzal M.A.
        • Buchanan J.
        • Dias J.A.
        • et al.
        RT-PCR based diagnosis and molecular characterisation of mumps viruses derived from clinical specimens collected during the 1996 mumps outbreak in Portugal.
        J Med Virol. 1997; 52: 349-353
        • Ogbuanu I.U.
        • Ketty P.K.
        • Hudson J.M.
        • et al.
        Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak.
        Pediatrics. 2012; 130: e1567-e1574
      3. Nelson G, Aguon AL, Quiambao E, et al. Third dose MMR intervention during a mumps outbreak in a highly vaccinated population—Guam 2009–2010. NIC 2011: 45th National Immunization Conference; 2011 Mar 28–31: Washington, DC.

        • Lane T.M.
        • Hines J.
        The management of mumps orchitis.
        BJU Int. 2006; 97: 1-2
        • Poggio G.P.
        • Rodriguez C.
        • Cisterna D.
        • et al.
        Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases.
        J Clin Microbiol. 2000; 38: 274-278
        • Enders M.
        • Rist B.
        • Enders G.
        Gynakol Geburtshilfliche Rundsch. 2005; 45 ([in German]): 39-43
        • Bowers D.
        Mumps during pregnancy.
        West J Surg Obstet Gynecol. 1953; 61: 72-73
        • Siegel M.
        Congenital malformations following chickenpox, measles, mumps, and hepatitis. Results of a cohort study.
        JAMA. 1973; 226: 1521-1524
        • Centers for Disease Control and Prevention (CDC)
        Updated recommendations for isolation of persons with mumps.
        MMWR Morb Mortal Wkly Rep. 2008; 57: 1103-1105
      4. Infections in immunocompromised infants and children, section I.
        in: Patrick C.C. Disorders of host defense. Churchill Livingstone, New York1992
        • Hibberd P.L.
        • Rubin R.H.
        Approaches to immunization in the immunocompromised host.
        Infect Dis Clin North Am. 1990; 4: 123-142
        • Centers for Disease Control and Prevention (CDC)
        Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence.
        MMWR Morb Mortal Wkly Rep. 1993; 42: 1-18
        • Kutty P.K.
        • Kyaw M.H.
        • Dayan G.H.
        • et al.
        Guidance for isolation precautions for mumps in the United States: a review of the scientific basis for policy change.
        Clin Infect Dis. 2010; 50: 1619-1628
        • Centers for Disease Control and Prevention (CDC)
        Public health resources: state or territorial health departments. MMWR Morb Mortal Wkly Rep.
        (Available at:)